AMAG : Summary for AMAG Pharmaceuticals, Inc. - Yahoo Finance

U.S. Markets closed

AMAG Pharmaceuticals, Inc. (AMAG)


NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
33.22+1.32 (+4.15%)
At close: 4:00 PM EST
People also watch:
ACORALNYANACAKRXAEGR
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
1d
Previous Close31.90
Open31.90
Bid31.05 x 100
Ask40.35 x 300
Day's Range31.40 - 34.00
52 Week Range17.92 - 34.42
Volume825,244
Avg. Volume754,280
Market Cap1.14B
Beta0.71
PE Ratio (TTM)76.38
EPS (TTM)N/A
Earnings DateN/A
Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • Is AMAG Pharmaceuticals, Inc. (AMAG) Going to Burn These Hedge Funds?
    Insider Monkey4 days ago

    Is AMAG Pharmaceuticals, Inc. (AMAG) Going to Burn These Hedge Funds?

    Billionaire hedge fund managers such as Steve Cohen and Stan Druckenmiller can generate millions or even billions of dollars every year by pinning down high-potential small-cap stocks and pouring cash into these candidates. Small-cap stocks are overlooked by most investors, brokerage houses, and financial services hubs, while the unlimited research abilities of the big players […]

  • AMAG Pharma (AMAG) Q3 Earnings Up Y/Y, Revenues Beat
    Zacks25 days ago

    AMAG Pharma (AMAG) Q3 Earnings Up Y/Y, Revenues Beat

    AMAG Pharmaceuticals, Inc. (AMAG) reported adjusted earnings of $1.61 per share in the third quarter of 2016, up approximately 77% from the year-ago figure.

  • Investopedia28 days ago

    AMAG Pharmaceuticals 3Q Net 43 Cents/Share (AMAG)

    AMAG's 3Q earnings and revenue beat analyst estimates due to robust sales of its Makena drug for pregnant women.